Celularity Inc (CELU)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20M 40M 60M Q2 '21: 12.5M Q3 '21: 19.7M Q4 '21: 21.3M Q1 '22: 24.6M Q2 '22: 25.2M Q3 '22: 18.7M Q4 '22: 18M Q1 '23: 16M Q2 '23: 15.1M Q3 '23: 14.8M Q4 '23: 22.8M Q1 '24: 33.5M Q2 '24: 42.7M Q3 '24: 48.2M Q4 '24: 54.2M Q1 '25: 51M Q2 '25: 44.6M Q3 '25: 40.6M Q4 '25: 26.6M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Gross Profit TTM

-5M 0 5M 10M 15M Q2 '21: 7.6M Q3 '21: 13.6M Q4 '21: 11.7M Q1 '22: 12.2M Q2 '22: 11M Q3 '22: -376K Q4 '22: -1.7M Q1 '23: -1.7M Q2 '23: -128K Q3 '23: 3.1M Q4 '23: 6.8M Q2 '21 Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23

Operating Income TTM

-210M -140M -70M 0 70M 140M 210M Q1 '20: -1.9M Q2 '20: -2M Q3 '20: -6.6M Q4 '21: -109.1M Q1 '22: -106.3M Q2 '22: -41.5M Q3 '22: -58M Q4 '22: -25.6M Q1 '23: -47.9M Q2 '23: -94.5M Q3 '23: -188.1M Q4 '23: -192.3M Q1 '24: -135.8M Q2 '24: -103.5M Q3 '24: -15.8M Q4 '24: -38.4M Q1 '25: -41.5M Q2 '25: -47.2M Q3 '25: -48.5M Q4 '25: -61.3M Q2 '20 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Net Income TTM

-210M -140M -70M 0 70M 140M 210M Q1 '21: -136.1M Q2 '21: -188.4M Q3 '21: -92.2M Q4 '21: -100.1M Q1 '22: -81.4M Q2 '22: 30.9M Q3 '22: -14.3M Q4 '22: 14.2M Q1 '23: 13M Q2 '23: -82.7M Q3 '23: -181.4M Q4 '23: -196.3M Q1 '24: -154.3M Q2 '24: -112.8M Q3 '24: -35.1M Q4 '24: -57.9M Q1 '25: -55.6M Q2 '25: -73.7M Q3 '25: -80.6M Q4 '25: -91.7M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Cost of Revenue TTM

0 7M 14M 21M Q4 '23: 16M Q1 '24: 15.7M Q2 '24: 17M Q3 '24: 17.3M Q4 '24: 15M Q1 '25: 16.9M Q2 '25: 20M Q3 '25: 20M Q4 '25: 20.1M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25

Operating Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q1 '21: -87.7M Q2 '21: -105.7M Q3 '21: -94.9M Q4 '21: -110.1M Q1 '22: -119.3M Q2 '22: -137.4M Q3 '22: -140.3M Q4 '22: -137.9M Q1 '23: -118.6M Q2 '23: -93.3M Q3 '23: -63.9M Q4 '23: -38.7M Q1 '24: -28.1M Q2 '24: -20.5M Q3 '24: -12.3M Q4 '24: -6.4M Q1 '25: -5M Q2 '25: -2.5M Q3 '25: -6.6M Q4 '25: -13.3M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Free Cash Flow TTM

-180M -120M -60M 0 60M 120M 180M Q3 '21: -108.2M Q4 '21: -116.3M Q1 '22: -125.4M Q2 '22: -143.7M Q3 '22: -147.1M Q4 '22: -143.1M Q1 '23: -122.6M Q2 '23: -95.9M Q3 '23: -65.2M Q4 '23: -39.7M Q1 '24: -29M Q2 '24: -21.4M Q3 '24: -13M Q4 '24: -6.6M Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '20: 18.4M Q2 '21: 24M Q3 '21: 123.6M Q1 '22: 130.4M Q2 '22: 151.3M Q3 '22: 150.5M Q1 '23: 15.5M Q2 '23: 17.7M Q3 '23: 18.8M Q1 '24: 21.4M Q2 '24: 21.8M Q3 '24: 22M Q1 '25: 23.5M Q2 '25: 24M Q3 '25: 26.3M Q3 '20 Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-21.00 -14.00 -7.00 0.00 7.00 14.00 21.00 Q1 '21: -17.18 Q2 '21: -19.87 Q3 '21: -16.95 Q4 '21: -1.49 Q1 '22: 1.43 Q2 '22: 4.44 Q3 '22: 4.07 Q4 '22: 0.89 Q1 '23: -2.75 Q2 '23: -5.79 Q3 '23: -10.80 Q4 '23: -11.02 Q1 '24: -7.93 Q2 '24: -5.51 Q3 '24: -1.26 Q4 '24: -2.65 Q1 '25: -2.46 Q2 '25: -3.18 Q3 '25: -3.33 Q4 '25: -3.59 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.